The Argentine government has officially approved the emergency use of an inactivated COVID-19 vaccine developed by Chinese pharmaceutical company Sinopharm, according to a resolution signed by the minister on Sunday. of Health Carla Vizzotti.
The resolution was signed by Ms. Vizzotti after the National Administration of Drugs, Food and Medical Technologies (ANMAT) advised the Ministry of Health to include Sinopharm’s vaccine in the national COVID vaccination plan. 19.
The minister’s spokesperson stressed that clinical trials of the vaccine have shown it to be “safe and effective”.
Sinopharm’s vaccine is the fifth authorized by Argentina, after that of Pfizer-BioNTech, Russian Sputnik V, Swedish-British AstraZeneca, and Covishield produced by the Serum Institute of India.
According to President Alberto Fernandez’s social media account, “more than 700,000 people have received doses of the COVID-19 vaccine and more than 400,000 people have already received both doses” (and are therefore immune).
“The vaccination rate will accelerate with the arrival of more vaccines in the country,” Fernandez said.
The South American country has recorded a total of 2,064,334 cases and 51,198 deaths, as of Sunday evening.
